Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
- PMID: 1471702
- DOI: 10.1016/0002-9378(92)91779-a
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
Abstract
Objective: Our purpose was to determine the prevalence of adrenal hyperandrogenism and insulin resistance in patients with hyperandrogenic chronic anovulation, also called polycystic ovary syndrome, living in the United States, Italy, and Japan.
Study design: Seventy-five women with polycystic ovary syndrome, 25 each from the United States, Italy, and Japan, and 10 ovulatory controls were studied. Hirsutism, obesity, and the presence of cystic ovaries were assessed, as were blood levels for estrogen, luteinizing hormone, testosterone, adrenal androgens, and insulin. All patients received an insulin tolerance test to assess insulin resistance.
Results: Women from Japan were less obese (p < 0.05) and did not have hirsutism, although the percentage of cystic ovaries (68% to 80%) was comparable. Serum luteinizing hormone, testosterone, and estradiol were similar, but levels of 3 alpha-androstanediol glucuronide, which was elevated in women from the United States and Italy, was normal in women from Japan. The adrenal androgens, dehydroepiandrosterone sulfate and 11 beta-hydroxyandrostenedione were elevated in 48% to 64% of the patients and by a similar percentage in the three groups. Fasting insulin was elevated in all groups, but was significantly higher in women from the United States and Italy compared with women from Japan (p < 0.05). However, insulin resistance as assessed by dissociation constant of insulin tolerance test values was significantly elevated but similar in the three groups and occurred in 68% to 76% of patients.
Conclusion: In polycystic ovary syndrome, although obesity and hirsutism vary according to dietary, genetic, and environmental factors, the prevalence of adrenal androgen excess and insulin resistance appear to be fairly uniform. These results suggest that these factors may be involved in the pathophysiologic features of the disorder.
Similar articles
-
Polycystic ovary syndrome.Endocrinol Metab Clin North Am. 1997 Dec;26(4):893-912. doi: 10.1016/s0889-8529(05)70286-3. Endocrinol Metab Clin North Am. 1997. PMID: 9429864 Review.
-
The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.J Clin Endocrinol Metab. 1993 May;76(5):1295-300. doi: 10.1210/jcem.76.5.8388405. J Clin Endocrinol Metab. 1993. PMID: 8388405
-
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.J Clin Endocrinol Metab. 1987 Sep;65(3):499-507. doi: 10.1210/jcem-65-3-499. J Clin Endocrinol Metab. 1987. PMID: 3305551
-
Polycystic ovaries in Hirsute women with normal menses.Am J Med. 2001 Dec 1;111(8):602-6. doi: 10.1016/s0002-9343(01)00979-2. Am J Med. 2001. PMID: 11755502
-
Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.Am J Med. 1995 Jan 16;98(1A):33S-39S. doi: 10.1016/s0002-9343(99)80057-6. Am J Med. 1995. PMID: 7825639 Review.
Cited by
-
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Endocr Rev. 2016 Oct;37(5):467-520. doi: 10.1210/er.2015-1104. Epub 2016 Jul 26. Endocr Rev. 2016. PMID: 27459230 Free PMC article. Review.
-
Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome.J Assist Reprod Genet. 2001 Aug;18(8):436-40. doi: 10.1023/a:1016686721307. J Assist Reprod Genet. 2001. PMID: 11599464 Free PMC article.
-
Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes.J Endocrinol Invest. 2007 Feb;30(2):111-6. doi: 10.1007/BF03347408. J Endocrinol Invest. 2007. PMID: 17392600
-
Waist Circumference Coupled with Either HDL-C or TG Can Be Used as a Diagnostic Marker for Metabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome.Int J Endocrinol. 2018 Sep 10;2018:6102085. doi: 10.1155/2018/6102085. eCollection 2018. Int J Endocrinol. 2018. PMID: 30275828 Free PMC article.
-
Tetragonia tetragonioides (Pall.) Kuntze Regulates Androgen Production in a Letrozole-Induced Polycystic Ovary Syndrome Model.Molecules. 2018 May 14;23(5):1173. doi: 10.3390/molecules23051173. Molecules. 2018. PMID: 29757997 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical